New urine test could spot bladder cancer early in remote greenland
NCT ID NCT06281691
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether a simple urine test (Xpert Bladder Cancer Detection Test) can accurately detect bladder cancer in people undergoing cystoscopy. Researchers enrolled 127 adults in Greenland, where access to urology services is limited. The goal was to see if the urine test could help decide who really needs a cystoscopy, potentially leading to earlier diagnosis and better outcomes.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Xpert® Bladder Cancer Detection Test (urine test)
- What this could lead to
- If successful, this urine test could help detect bladder cancer earlier in remote areas with limited access to specialists, potentially improving survival.
- What could go wrong
- This is a small, completed observational study (127 participants) testing accuracy, not a treatment. The urine test may not be reliable enough to replace cystoscopy in all cases.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for URINARY BLADDER NEOPLASMS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Department of Urology, Aarhus University Hopsital
Aarhus, 8000, Denmark
-
Queen Ingrid's Hospital
Nuuk, 3900, Greenland
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can AI outthink cancer experts? a landmark trial pits five AIs against tumor boards
- Bladder cancer surgery: what happens after the bladder is removed?
- Bladder cancer drug delivered directly: a new hope for BCG failures
- New drug option for Hard-to-Treat cancers with FGFR3 mutations
- New hope for bladder cancer: targeted drug combo aims to boost survival
- AI doctor takes on urology: can a chatbot outperform human specialists?